Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

29 Mar 2012

Abstract excerpt

Recent EUCAST advice asserts that, with low breakpoints, susceptibility results for cephalosporins and carbapenems can be reported 'as found', even for strains with extended-spectrum β-lactamases (ESBLs) and carbapenemases. The CLSI has similar advice, but with higher ceftazidime and cefepime breakpoints than those of EUCAST. Pharmacodynamic and animal data are used to support these views, along with some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22461311
DOI: 10.1093/jac/dks088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?PMID 22461311Read ↗

Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utilitySemantic proximity Read ↗

Positive Extended-Spectrum-β-Lactamase (ESBL) Screening Results May Be Due to AmpC β-Lactamases More Often than to ESBLsSemantic proximity Read ↗

The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?Semantic proximity Read ↗

The fluoroquinolones: How long will their utility last?Semantic proximity Read ↗

The cost-effectiveness of ESBL detection: towards molecular detection methods?Semantic proximity Read ↗

What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?Semantic proximity Read ↗

Improving the detection of carbapenemase-producing organisms (CPO) in a low-prevalence setting: evaluation of four commercial methods and implementation of an algorithm of testing.Semantic proximity Read ↗

Innovative approaches in phenotypic beta-lactamase detection for personalised infection management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.